These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21118387)

  • 41. A new allelic discrimination assay using locked nucleic acid-modified nucleotides (LNA) probes for detection of JAK2 V617F mutation.
    Marková J; Průková D; Volková Z; Schwarz J
    Leuk Lymphoma; 2007 Mar; 48(3):636-9. PubMed ID: 17454614
    [No Abstract]   [Full Text] [Related]  

  • 42. Optimization of a Low-Cost, Sensitive PNA Clamping PCR Method for JAK2 V617F Variant Detection.
    Di Francia R; Crisci S; Muto T; Giancola C; Petriccone L; Catapano O; Cummarro A; Pinto A; Frigeri F
    J Appl Lab Med; 2020 Jul; 5(4):643-655. PubMed ID: 32407536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.
    Ma W; Kantarjian H; Zhang X; Yeh CH; Zhang ZJ; Verstovsek S; Albitar M
    J Mol Diagn; 2009 Jan; 11(1):49-53. PubMed ID: 19074595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population.
    Pagliarini-e-Silva S; Santos BC; Pereira EM; Ferreira ME; Baraldi EC; Sell AM; Visentainer JE
    Clinics (Sao Paulo); 2013 Jan; 68(1):5-9. PubMed ID: 23420150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms.
    Haslam K; Molloy KM; Conneally E; Langabeer SE
    Clin Chem Lab Med; 2014 Mar; 52(3):e29-31. PubMed ID: 24423581
    [No Abstract]   [Full Text] [Related]  

  • 46. [The development and comparative approbation of methods of increasing sensitivity of detection of mutation V617F in gene JAK2 by pyro-sequencing].
    Dunaeva EA; Mironov KO; Subbotina TN; Olkhovsky IA; Shipulin GA
    Klin Lab Diagn; 2017 Feb; 62(2):125-8. PubMed ID: 30615403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia.
    Kaeda J; Bonamino M; Ayres-Silva J; Solza C; Ringel F; Blau O; Daumas A; Oberender C; Dörken B; le Coutre P; Zalcberg I
    Leuk Lymphoma; 2014 Jan; 55(1):128-35. PubMed ID: 23607255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The quantitative testing of V617F mutation in gen JAK2 using pyrosequencing technique].
    Dunaeva EA; Mironov KO; Dribnokhodova TE; Subbotina EE; Bashmakova ; Ol'hovskiĭ IA; Shipulin GA
    Klin Lab Diagn; 2014 Nov; 59(11):60-3. PubMed ID: 25850251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease.
    Asadzadeh-Aghdaei H; Mashayekhi K; Koushki K; Azimzadeh P; Rostami-Nejad M; Amani D; Chaleshi V; Haftcheshmeh SM; Sahebkar A; Zali MR
    J Cell Biochem; 2019 Sep; 120(9):15746-15755. PubMed ID: 31069840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative evaluation of three JAK2V617F mutation detection methods.
    Frantz C; Sekora DM; Henley DC; Huang CK; Pan Q; Quigley NB; Gorman E; Hubbard RA; Mirza I
    Am J Clin Pathol; 2007 Nov; 128(5):865-74. PubMed ID: 17951211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early renal arterial stent thrombosis associated with the JAK2 V617F mutation.
    Tabaczewski P; Nadesan S; Lim SH
    Leuk Res; 2009 Apr; 33(4):573-4. PubMed ID: 18639337
    [No Abstract]   [Full Text] [Related]  

  • 52. JAK out of the box: myeloproliferative neoplasms--associated JAK2 V617F mutations contribute to aortic aneurysms.
    Elf SE
    Haematologica; 2021 Jul; 106(7):1783-1784. PubMed ID: 33567815
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of a highly sensitive method for detection of JAK2V617F.
    Zhao AH; Gao R; Zhao ZJ
    J Hematol Oncol; 2011 Oct; 4():40. PubMed ID: 21985400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of low level JAK2 V617F in peripheral blood testing.
    Rubic M; Lee L; Stevenson W
    Pathology; 2024 Aug; 56(5):726-728. PubMed ID: 38395679
    [No Abstract]   [Full Text] [Related]  

  • 55. [JAK2 mutation and thrombosis - recommendations for screening].
    Held M
    Dtsch Med Wochenschr; 2012 Feb; 137(5):227. PubMed ID: 22278696
    [No Abstract]   [Full Text] [Related]  

  • 56. Absence of FLT3 and JAK2 (V617F) mutations in Langerhans cell histiocytosis.
    Abedalthagafi M; Guo H; Hartmann DP; Ozdemirli M
    Leuk Res; 2009 Sep; 33(9):e173-4. PubMed ID: 19395028
    [No Abstract]   [Full Text] [Related]  

  • 57. Absence of JAK2 exon 12 mutation in acute leukemias.
    Jeong EG; Kim SH; Kim MS; Lee SH; Yoo NJ
    Acta Haematol; 2008; 119(1):38-9. PubMed ID: 18230964
    [No Abstract]   [Full Text] [Related]  

  • 58. "
    Langabeer SE
    J Cancer Prev; 2019 Mar; 24(1):59-60. PubMed ID: 30993097
    [No Abstract]   [Full Text] [Related]  

  • 59. Summary and Review of the Abstracts on Philadelphia-Negative Myeloproliferative Neoplasms Presented at Haematocon 2017.
    Chatterjee T; Ahuja A
    Indian J Hematol Blood Transfus; 2018 Apr; 34(2):227-232. PubMed ID: 29622863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a PCR Assay for Diagnosing Trematode (Opisthorchis and Haplorchis) Infections in Human Stools.
    Lamaningao P; Kanda S; Laimanivong S; Shimono T; Darcy AW; Phyaluanglath A; Mishima N; Nishiyama T
    Am J Trop Med Hyg; 2017 Jan; 96(1):221-228. PubMed ID: 27821695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.